Skip to main content
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. — Investor Relations & Filings

Ticker · LNTH ISIN · US5165441032 LEI · 5299005HUB5IOJGO7S39 US Manufacturing
Filings indexed 1,028 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US LNTH

About Lantheus Holdings, Inc.

https://www.lantheus.com/

Lantheus Holdings, Inc. is a leading company focused on radiopharmaceuticals, specializing in the development, manufacturing, and commercialization of precision diagnostic and therapeutic products. Its portfolio is designed to assist clinicians in the diagnosis, treatment, and monitoring of various diseases. The company provides diagnostic imaging agents, targeted radiotherapeutics, and leverages artificial intelligence solutions to enhance clinical decision-making. Lantheus's strategy is centered on a 'Find, Fight, and Follow' approach to patient care, aiming to improve outcomes by delivering critical information throughout the disease management process.

Recent filings

Filing Released Lang Actions
10-Q - Lantheus Holdings, Inc. (0001521036) (Filer)
Interim / Quarterly Report
2026-05-07 English
8-K - Lantheus Holdings, Inc. (0001521036) (Filer)
Regulatory Filings
2026-05-07 English
8-K - Lantheus Holdings, Inc. (0001521036) (Filer)
Regulatory Filings
2026-05-01 English
SCHEDULE 13G/A - Lantheus Holdings, Inc. (0001521036) (Subject)
Major Shareholding Notification
2026-03-27 English
ARS - Lantheus Holdings, Inc. (0001521036) (Filer)
Annual Report
2026-03-20 English
DEFA14A - Lantheus Holdings, Inc. (0001521036) (Filer)
Regulatory Filings
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.